All Wales Strategic Medical Group Approves Zebinix Anti-Epileptic Treatment
Thursday, November 22, 2012 - 05:31
in Health & Medicine
The All Wales Strategic Medical Group (AWSMG) has approved Zebinix(R) (eslicarbazepine acetate) for the treatment of partial seizures in highly refractory patients who remain uncontrolled with, or are intolerant to, other anti-epileptic medicine combinations. Eslicarbazepine acetate is licensed in Europe as an adjunctive therapy for adults with partial-onset seizures with or without secondary generalization. read more